ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bicycle Therapeutics, Ionic Pharma Enter License & Collaboration Agreement
July 14, 2021Ionis Pharmaceuticals has exercised its option and entered into an exclusive worldwide license and collaboration agreement with Bicycle Therapeutics for tissue-targeted delivery of oligonucleotide therapeutics using Bicycle’s proprietary bicyclic ... -
Cancer Research UK to fund Bicycle’s immuno-oncology candidate
January 09, 2020Cancer Research UK has agreed to fund exploratory development of Bicycle Therapeutics’ immuno-oncology candidate BT7401. -
Bicycle hires clinical leader ahead of IPO-fueled pipeline push
May 10, 2019Bicycle Therapeutics has hired clinical and program management leaders to support development of its anticancer candidates. The hires provide Bicycle with clinical trial expertise at a time when it is contending with the resignation of its chief medical o -
Bicycle and DDF collaborate on drug development for CNS conditions
May 09, 2019UK-headquartered Bicycle Therapeutics and venture capital fund Dementia Discovery Fund (DDF) have entered into a collaboration to use the former’s bicyclic peptide technology to identify new targets and development novel therapeutics for neurodegenerative
Pharma Sources Insight January 2025
